EBV Infection Clinical Trials

7 recruitingLast updated: June 21, 2026

There are 7 actively recruiting ebv infection clinical trials across 9 countries. Studies span Phase 1, Not Applicable, Phase 3, Phase 4. Top locations include Beijing, Beijing Municipality, China, Ghent, Belgium, Brussels, Belgium. Updated daily from ClinicalTrials.gov.


EBV Infection Trials at a Glance

7 actively recruiting trials for ebv infection are listed on ClinicalTrialsFinder across 6 cities in 9 countries. The largest study group is Phase 1 with 2 trials, with the heaviest enrollment activity in Beijing, Ghent, and Brussels. Lead sponsors running ebv infection studies include Chinese PLA General Hospital, Huazhong University of Science and Technology, and Labo'Life.

Browse ebv infection trials by phase

Treatments under study

About EBV Infection Clinical Trials

Looking for clinical trials for EBV Infection? There are currently 5 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new EBV Infection trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about EBV Infection clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting

A Registry for People With T-cell Lymphoma

T-cell LymphomaNK-Cell LymphomaT-cell Prolymphocytic Leukemia+27 more
Memorial Sloan Kettering Cancer Center1,000 enrolled26 locationsNCT05978141
Recruiting
Phase 1

Clinical Study of EBV-TCR-T Cells for EBV Infection After Allogenic HSCT

EBV Infection After Allogenic HSCT
Chinese PLA General Hospital12 enrolled1 locationNCT06119256
Recruiting
Not Applicable

Is Valacyclovir Non-inferior to Valganciclovir as CMV and EBV Prophylaxis in Kidney Transplant Recipients? A Single-Center Prospective Randomized Pilot Study

Kidney Transplantation, Cytomegalovirus InfectionsEBV InfectionAntiviral Prophylaxis
National Taiwan University Hospital80 enrolled1 locationNCT07294547
Recruiting
Phase 3

Multivirus-specific T-cell Transfer Post SCT vs AdV, CMV and EBV Infections

Stem Cell Transplant ComplicationsEBV InfectionCMV Infection+1 more
Tobias Feuchtinger149 enrolled33 locationsNCT04832607
Recruiting
Phase 4

Study to Evaluate the Efficacy of 2LEBV® and 2LXFS® on Asthenia in Patients With an Epstein-Barr Virus Infection

EBV Infection
Labo'Life88 enrolled12 locationsNCT04308278
Recruiting
Phase 1

Clinical Study of EBV-TCR-T Cells for EBV-associated Hemophagocytic Lymphohistiocytosis or EBV Infection

EBV InfectionEBV-associated Hemophagocytic Lymphohistiocytosis
Chinese PLA General Hospital9 enrolled1 locationNCT06135922
Recruiting

Surveillance and Tracking the Outcomes of Chronic Latent EBV Infection

EBV Infection
Huazhong University of Science and Technology10,000 enrolled1 locationNCT03491605